As Toronto hosts the 2026 FIFA World Cup, the city is welcoming large crowds, international visitors and volunteers into stadiums, transit hubs, fan spaces and public areas. For many people, the World Cup is about soccer, ...
Jun 16, 2026
0
1
The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, an international team of investigators led by Weill Cornell Medicine found.
Jun 11, 2026
0
5
Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but underrecognized burden of illness, hospitalization ...
Jun 6, 2026
0
9
Dr. Jeffery Taubenberger, who has been serving as acting head of the National Institute for Allergy and Infectious Diseases (NIAID) for just over a year, has stepped down for unknown reasons.
May 25, 2026
0
23
A large, multi-center study led by Ann & Robert H. Lurie Children's Hospital of Chicago has derived achievable benchmarks of care (ABCs) using electronic health record data, which allows pediatric emergency departments across ...
May 19, 2026
0
6
The American Academy of Microbiology, the honorific leadership group and scientific think tank within the American Society for Microbiology (ASM), and the American Geophysical Union (AGU) released a new report examining how ...
May 15, 2026
0
4
Modern medicine prides itself on being a universal science, built on evidence from clinical trials.
May 4, 2026
0
2
Lung transplant recipients require intensive, ongoing monitoring after transplant to detect complications such as rejection or infection. Now, in a study published in JHLT Open, Mayo Clinic researchers have found that remote ...
Apr 29, 2026
0
4
Europe is facing a sharp rise in heat-related deaths, deteriorating working conditions, growing food insecurity, and increased risks of climate-sensitive infectious diseases, according to a new report on climate change and ...
Apr 22, 2026
0
5
Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to ...
